CELL CULTURE TECHNOLOGY
Cell culture technology, utilized in Wincell Research’s cell culture laboratory, adheres to strict standards and safety protocols for medical research and applications. Currently, we provide cell culture services for three main groups:
- Dendritic cells (DCs) for cancer vaccine development.
- Killer cells in the immune system.
- Peripheral blood stem cells (PBSCs).
1. Dendritic Cells for Cancer Vaccine Development
WT1-pulsed DC cancer vaccine
Wincell Research offers dendritic cell culture and stimulation for cancer vaccine development, using technology licensed from Japan. Wincell Research holds the exclusive rights to provide this service in Thailand.
What are Dendritic Cells (DCs)?
Dendritic cells act as “middlemen” or “coordinators” between the innate and specific immune systems, enabling the body to respond effectively to pathogens or abnormal cells. This property makes dendritic cells applicable in cancer vaccine development by stimulating the immune system to recognize and destroy cancer cells with greater specificity.
Dendritic cells are cells in the innate immune system that detect and present foreign substances or antigens to other immune cells, especially T cells (Killer T cells or Cytotoxic T cells), which are responsible for destroying foreign bodies and infected cells in the body.
2. Killer Cells in the Immune System
We provide culture and stimulation services for integrative killer cells, including both immune cell groups with Natural Killer (NK) cells and immune cell groups with T cells (Killer T cells) as the main components.
Why are Killer Cells Important?
Killer cells are essential for an effective immune system, helping to eliminate foreign bodies that enter the body. Healthy and sufficient numbers of killer cells indicate the immune system’s ability to fight diseases, especially cancer.
3. Peripheral Blood Stem Cells (PBSCs)
Autologous Peripheral blood stem cells: PBSCs
These are stem cells or progenitor cells from the bloodstream. They can be stimulated by G-CSF, a bone marrow stimulating agent that the human body can produce naturally, to sufficiently increase for standardized process of collection and quality preservation, ensuring availability for future use, particularly for diseases related to the blood and immune systems.
